contact us
subTop OurProjects

Bronchial asthma (BA) is one of the most common chronic illnesses in children with a prevalence of more than 14% globally. Evidence shows that the prevalence of asthma in children is increasing with 10 million (2011) children being diagnosed with asthma during their lifetime in the US alone, of which 1.7 million are aged below 4 years. The recommended treatment for BA for children is by the aid of the use of a pressurized metered-dose inhaler (pMDI) attached to spacers. However, current available spacers have major limiting issues relating to poor administration technique and low compliance in children.

The Whizz spacer offer a simple tool that will simplify asthma management for children and their parents, by reinforcing correct technique with every use and ensure compliance, everyday. By having access to accurate and objective data, physicians will be able to evaluate progress and adjust treatment. This will benefit asthma treatment and asthma control, in addition to other respiratory conditions, reducing morbidity and mortality of BA.

 

Project Deliverables

The team aims to i) Hardware and firmware design and optimization, and ii) Clinical validation


Principal Investigator: Prof. Hugo van Bever

Institution: National University Health System

NHIC Ref: NHIC-I2D-1708172

 

 

See all MEDTECH projects >

targetGroup_clinicianInnovators
targetGroup_ResearchAdministrator
targetGroup_IndustryPartner
targetGroup_Investor